Clinical trial data suggest the Wegovy pill and injection produce similar weight loss results
Recalls & Warnings February 02, 2026 Organic Psyllium Husk Powder Recalled in Canada Due to Insects On January 21, 2026, the Canadian Food Inspection Agency (the Canadian equivalent of the FDA) advised consumers that Persona Creations Inc
Jun 07, 2026, 17:30 ET CagriSema, a once-weekly investigational treatment that combines a novel amylin analog with a GLP-1 receptor agonist (RA), achieved significant reductions in HbA 1c and bodyweight versus comparators across three phase 3 trials in adults with type 2 diabetes (T2D) 1-3 Data from the REIMAGINE clinical development program, a series of phase 3 trials evaluating once-weekly CagriSema in adults with T2D across various stages of their disease, were presented at an ADA symposium 1-3 Novo Nordisk continues to demonstrate pioneering leadership and scientific innovation through advancing diabetes research PLAINSBORO, N.J
Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover
Diamond, MD, FACS Center for Advanced Urology Moorestown, NJ Peptide therapy has become one of the most promising new tools in sexual health, hormone balance, injury recovery, metabolic health, and longevity medicine
Clinical evidence demonstrates that GLP-1 RAs are an effective means of reducing the risk of MACE in diabetic patients